Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study

British Journal of Dermatology

Volumn 176, Issue 3, 2017, Pages 650-658

  Springate, D A ^a   Parisi, R ^b   Kontopantelis, E ^a,b   Reeves, D ^a   Griffiths, C E M ^a   Ashcroft, D M ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRONIC HEALTH RECORD; FEMALE; FOLLOW UP; HUMAN; INFANT; LATITUDE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MORTALITY RATE; NEWBORN; PRIORITY JOURNAL; PSORIASIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; AGE DISTRIBUTION; CLINICAL TRIAL; DEMOGRAPHY; EPIDEMIOLOGY; MULTICENTER STUDY; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MORTALITY; PSORIASIS; RESIDENCE CHARACTERISTICS; UNITED KINGDOM; YOUNG ADULT;

EID: 85007044898     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15021     Document Type: Article

References (30)

1. Gelfand JM, Feldman SR, Stern RS et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51:704–8.
2. Rapp SR, Feldman SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:401–7.
3. Stern RS, Nijsten T, Feldman SR et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 2004; 9:136–9.
4. Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133:377–85.
5. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ 1996; 313:919–21.
6. Bø K, Thoresen M, Dalgard F. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. Dermatology 2008; 216:40–5.
7. World Health Organization (WHO). 67th World Health Assembly: Psoriasis. WHA67·9. Geneva: WHO, 2014.
8. World Health Organization (WHO). Global Report on Psoriasis. Geneva: World Health Organization, 2016.
9. Horreau C, Pouplard C, Brenaut E et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 2013; 27:12–29.
10. Ogdie A, Haynes K, Troxel AB et al. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheu Dis 2012; 73:149–53.
11. Office of National Statistics (ONS). National Life Tables, United Kingdom, 2012–2014. London: Office of National Statistics, 2015.
12. Health and Social Care Information Centre (HSCIC). Attribution Data Set GP-Registered Populations Scaled to ONS Population Estimates – 2011. Leeds: HSCIC, 2012.
13. Kontopantelis E, Buchan I, Reeves D et al. Relationship between quality of care and choice of clinical computing system: retrospective analysis of family practice performance under the UK's quality and outcomes framework. BMJ Open 2013; 3:e003190.
14. Herrett EGA, Bhaskaran K, Forbes H et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol 2015; 44:827–36.
15. Department for Communities and Local Government (DCLG). The English Indices of Deprivation 2010. Neighbourhoods Statistical Release. London: DCLG, 2011.
16. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2014.
17. Stevenson M. epiR: Tools for the analysis of epidemiological data, Available at: ftp://cran.r-project.org/pub/R/web/packages/epiR/epiR.pdf, (last accessed 15 December 2016).
18. Springate DA, Kontopantelis E, Ashcroft DM et al. ClinicalCodes: an online clinical codes repository to improve the validity and reproducibility of research using electronic medical records. PLOS ONE 2014; 9:e99825.
19. Johnson M, Roberts J. Skin conditions and related need for medical care among persons 1–74 years. United States, 1971–1974. Vital Health Stat 1978; 212:1–72.
20. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol 2009; 60:218–24.
21. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol 2013; 168:1303–10.
22. Ferrandiz C, Bordas X, Garcia-Patos V. Prevalence of psoriasis in Spain (Epiderma Project: phase I). J Eur Acad Dermatol Venereol 2001; 15:20–3.
23. Ferrándiz C, Carrascosa JM, Toro M. Prevalence of psoriasis in Spain in the age of biologics. Actas Dermo-Sifiliográficas 2014; 105:504–9.
24. Tollefson MM, Crowson CS, McEvoy MT. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol 2010; 62:979–87.
25. Icen M, Crowson CS, McEvoy MT et al. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60:394–401.
26. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13:450–6.
27. Gelfand JM, Weinstein R, Porter SB et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141:1537–41.
28. Kontopantelis E, Springate D, Reeves D et al. Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework. BMJ 2014; 348:g330.
29. Huerta C, Rivero E, Rodríguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143:1559–65.
30. Seminara NM, Abuabara K, Shin DB et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 2011; 164:602–9.